An mRNA CRDMO company built around LNP delivery technology
Yixing, Jiangsu, ChinaBiotech
7 sources · checked 4 times, last 1h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source reports total proceeds exceeding RMB 100 million across the angel and Pre-A rounds, without allocating an amount to either round; therefore no round-specific amount is stated.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed angel round and a Pre-A round | total proceeds exceeding RMB 100M total raised | 2026-10-29 | Addor Capital, Tenykin Capital | No recent discussion |
7 sources · checked 4 times, last 1h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 7 sources
The source reports total proceeds exceeding RMB 100 million across the angel and Pre-A rounds, without allocating an amount to either round; therefore no round-specific amount is stated. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]7 pages read: marketscreener.com, google.com, vcbeathealth.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 4 of 7 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Enorna builds end-to-end mRNA and LNP drug-development and manufacturing services for biotech and pharmaceutical companies, from sequence design through commercial GMP production.
Checked against 8 sources 3d ago